Skip to content

Clinical trials

Observational Choroidal Neovascularization trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Choroidal Neovascularization Phase: Observational Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20042
20061
20074
20086
20092
20102
20112
20121
20141
20152
20161
20171
20182
20191
20203
20212
20221
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Unknown status6
Terminated3
Withdrawn2
Not yet recruiting2
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Notal Vision Ltd.7
Bayer3
National Eye Institute (NEI)2
Adverum Biotechnologies, Inc.1
Assistance Publique - Hôpitaux de Paris1
Assiut University1
Barnes Retina Institute1
Beijing Hospital1
Center for Eye Research Australia1
Changhua Christian Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Choroidal Neovascularization42
Macular Degeneration25
Central Serous Chorioretinopathy2
Diabetic Retinopathy2
Geographic Atrophy2
Myopia2
Polypoidal Choroidal Vasculopathy2
Retinal Diseases2
Wet Macular Degeneration2
Angioid Streaks1

Trials

Showing 51 to 42 of 42. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.